The Department of Medical Sciences and the National Vaccine Institute (NVI) have reported that the COVID-19 vaccine will be registered with the Food and Drug Administration (FDA) on February 14, and the first phase of the vaccination will be given to high-risk group, medical personnel, volunteers, and military and police officers at screening points.
Health Minister Anutin Charnvirakul said a new sub-committee would discuss how best to inform the public about the vaccine.
It will be Thailand’s most ambitious rollout ever — about half the population will receive free jabs, the goal being to achieve herd immunity. The challenge is that Covid-19 is unprecedented and vaccines have been developed in record time, a year, whereas previous vaccines often took four or five years to develop and test.
The Director-General of the Department of Medical Sciences, Dr. Supakit Sirilak, said a number of factors must be taken into consideration in the vaccination distribution process. They include health, economic and social security when compared to other countries, as well as international practices. The objective is to reduce the morbidity and mortality rates.
The first doses will be administered to high-risk groups, such as people with congenital diseases, respiratory diseases, chronic kidney disease, stroke, cancer, diabetes, blood pressure conditions and the elderly. The first doses will also be given to medical personnel and public and private health workers who are on the front line, such as volunteers, military and police officers at screening points in five at-risk provinces. The vaccine requires two doses, a month apart.
Venues, personnel and registration services must be prepared before they can be implemented nationwide. People will be able to receive the vaccine near their home. Before receiving the vaccine, the recipients must register and allow health authorities to monitor them via an application, to make sure that they are administered twice.